Role of UBE3A in the Central Nervous System

UBE3A 在中枢神经系统中的作用

基本信息

  • 批准号:
    8612194
  • 负责人:
  • 金额:
    $ 32.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-02-01 至 2018-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary Despite the genetic heterogeneity underlying autism and neurodevelopmental syndromes with autism comorbidity, there is phenotypic convergence among these disorders, leading to the view that this may reflect a common pathological convergence in cortical circuits. A leading theory suggests that an increased ratio of excitatory to inhibitory (E/I) neurotransmission (i.e., E/I imbalance) within neocortical circuits contributes to the common phenotypic features of autism. To gain a genetic toehold for understanding E/I imbalance, we have focused on an autism disorder associated with changes in a single gene, UBE3A. Loss of UBE3A expression causes Angelman syndrome (AS), which is characterized by an absence of speech, cognitive disability, seizures, and a high comorbidity with autism. We recently demonstrated that inhibitory drive onto cortical pyramidal neurons is severely decreased in a mouse model of AS, resulting in an elevated E/I ratio. Our preliminary data led us to hypothesize that the E/I imbalance caused by loss of UBE3A protein reflects both presynaptic defects in inhibitory interneurons and postsynaptic defects in pyramidal neurons. We further hypothesize that UBE3A function is required to maintain cortical E/I balance, and therefore we predict that loss of UBE3A even in adults will increase seizure susceptibility and cognitive deficits associated with elevated E/I ratio. Furthermore, we hypothesize that reinstatement of Ube3a expression will restore cortical E/I balance and reverse some AS phenotypes. In this proposal we aim to (1) Elucidate the cellular basis of cortical E/I imbalance in AS; (2) Test the hypothesis that Ube3a expression is required throughout life to maintain cortical E/I balance and neurotypical behaviors; (3) Define treatment windows for AS phenotypes. Our research will help establish parameters for therapeutic interventions in AS and possibly other autism spectrum disorders.
项目概要 尽管自闭症和神经发育障碍背后存在遗传异质性 患有自闭症合并症的综合征,这些之间存在表型趋同 疾病,导致人们认为这可能反映了共同的病理趋同 在皮质回路中。一个主要理论表明,兴奋性与 新皮质回路内的抑制性 (E/I) 神经传递(即 E/I 失衡) 有助于自闭症的共同表型特征。为了获得基因立足点 了解 E/I 失衡后,我们重点关注与以下疾病相关的自闭症: 单个基因 UBE3A 的变化。 UBE3A 表达缺失导致 Angelman 综合症(AS),其特征是无法言语、认知障碍、 癫痫发作,并且与自闭症有很高的合并症。我们最近证明了抑制 在 AS 小鼠模型中,皮质锥体神经元的驱动力严重降低, 导致 E/I 比升高。我们的初步数据使我们假设 E/I UBE3A 蛋白缺失引起的失衡反映了突触前缺陷 抑制性中间神经元和锥体神经元的突触后缺陷。我们进一步 假设需要 UBE3A 功能来维持皮质 E/I 平衡,并且 因此我们预测,即使在成人中,UBE3A 的缺失也会增加癫痫发作的几率 易感性和认知缺陷与 E/I 比率升高相关。此外,我们 假设恢复 Ube3a 表达将恢复皮质 E/I 平衡 逆转某些 AS 表型。在本提案中,我们的目标是 (1) 阐明细胞基础 AS 皮质 E/I 失衡的影响; (2) 检验Ube3a表达量的假设 终生需要维持皮质 E/I 平衡和神经典型行为; (3) 定义 AS 表型的治疗窗口。我们的研究将有助于建立 AS 和可能的其他自闭症谱系的治疗干预参数 失调。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BENJAMIN D PHILPOT其他文献

BENJAMIN D PHILPOT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BENJAMIN D PHILPOT', 18)}}的其他基金

Investigating UBE3A as a driver gene in Duplication 15q syndrome
研究 UBE3A 作为 15q 重复综合征的驱动基因
  • 批准号:
    10566815
  • 财政年份:
    2023
  • 资助金额:
    $ 32.13万
  • 项目类别:
TCF4 in Pitt-Hopkins syndrome
皮特-霍普金斯综合征中的 TCF4
  • 批准号:
    10459528
  • 财政年份:
    2019
  • 资助金额:
    $ 32.13万
  • 项目类别:
TCF4 in Pitt-Hopkins syndrome
皮特-霍普金斯综合征中的 TCF4
  • 批准号:
    10226316
  • 财政年份:
    2019
  • 资助金额:
    $ 32.13万
  • 项目类别:
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes
UBE3A 功能获得和亲本对神经发育表型的影响
  • 批准号:
    10441267
  • 财政年份:
    2019
  • 资助金额:
    $ 32.13万
  • 项目类别:
TCF4 in Pitt-Hopkins syndrome
皮特-霍普金斯综合征中的 TCF4
  • 批准号:
    10680426
  • 财政年份:
    2019
  • 资助金额:
    $ 32.13万
  • 项目类别:
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes
UBE3A 功能获得和亲本对神经发育表型的影响
  • 批准号:
    10645010
  • 财政年份:
    2019
  • 资助金额:
    $ 32.13万
  • 项目类别:
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes
UBE3A 功能获得和亲本对神经发育表型的影响
  • 批准号:
    10196989
  • 财政年份:
    2019
  • 资助金额:
    $ 32.13万
  • 项目类别:
TCF4 in Pitt-Hopkins syndrome
皮特-霍普金斯综合征中的 TCF4
  • 批准号:
    10023965
  • 财政年份:
    2019
  • 资助金额:
    $ 32.13万
  • 项目类别:
Role of UBE3A in the Central Nervous System
UBE3A 在中枢神经系统中的作用
  • 批准号:
    8995135
  • 财政年份:
    2014
  • 资助金额:
    $ 32.13万
  • 项目类别:
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome
Ube3a 的表观遗传调控作为天使综合征的治疗方法
  • 批准号:
    8396378
  • 财政年份:
    2011
  • 资助金额:
    $ 32.13万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.13万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.13万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.13万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.13万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.13万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.13万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.13万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.13万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.13万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.13万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了